On September 7th, California Life Sciences and our member Johnson & Johnson Innovation will come together to co-host our West Coast Symposium focusing on Cell and Gene Therapy – Advancing Next Generation Therapies.
9:30am | Registration Opens
10:00am | Opening Remarks
Melinda Richter, Global Head, Johnson & Johnson Innovation JLABS & Mike Guerra, President and Chief Executive Officer, California Life Sciences
10:10-10:30am | Keynote Speaker
Dr. David B. Miklos, Chief, BMT & Cellular Therapy, Professor of Medicine, Stanford University
10:30-10:50am | Fireside Chat
Rich Tillyer, Global Head of Discovery, Product Development and Supply, Johnson & Johnson with Edwin (Ed) Hill, Patient Advocate
10:50-11:10am | Break & Poster Voting
11:10am-12:00pm | Panel: Investment – Funding, Opportunities, & Challenges
Sponsored by Centre for Commercialization of Regenerative Medicine, CCRM
Moderated by: Asish Xavier, Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC
Panelists: Shyam Patel, Director of Business Development, California Institute for Regenerative Medicine – CIRM; Eric Shiosaki, Partner, DCVC Bio; Nancy Hong, Managing Director, RiverVest; Cynthia Levoie, AllosteRx and Centre for Commercialization of Regenerative Medicine – CCRM
12:00-1:00pm | Luncheon & Poster Voting
1:00-1:40pm | Panel: Scientific – Next Gen CAR Design and Screening
Moderated by: Chuck Drake, VP Immuno-Oncology, Johnson & Johnson
Panelists: Andreia Costa, Director, Cell Therapy Platform Discovery, Johnson & Johnson; Justin Farlow, Chief Technology Officer, Serotiny; Aaron Foster, Chief Scientific Officer, Outpace Bio; Jordan Jarjoun, Chief Scientific Officer, Moonlight Bio
1:40-2:00pm | Break & Poster Voting
2:00-2:50pm | Panel: Advances in Manufacturing
Sponsored by OmniaBio
Moderated by: Michael May, President and Chief Executive Officer, Centre for Commercialization of Regenerative Medicine – CCRM*
Panelists: John Knighton, VP Cell & Gene Therapy, Johnson & Johnson; Ian Gaudet, Senior Director and Site Head, Miltenyi Biotec; Mazen Karaman, Director of Platform Management, Resilience; Fabian Gerlinghaus, Chief Executive Officer, Cellares; Jenifer Wheat, Chief Commercial Officer, OmniaBio*
2:50-3:00pm | Closing Remarks
Melinda Richter, Global Head, Johnson & Johnson Innovation JLABS & Mike Guerra, President and Chief Executive Officer, California Life Sciences
3:00-5:00pm | Networking Reception & Poster Viewing, sponsored by Agilent
*Invited
Program under development, speakers subject to change.
Applications are now closed. Please join us on September 7th to view the pitches and vote for your favorite QuickPitch finalist!
Thank you to our esteemed panel of judges who will meet with each of the selected finalists in-person.
Sponsorship opportunities are available – demonstrate your thought leadership, broaden your network, and gain corporate visibility. Contact Emily Morgan ([email protected]) to learn more.